PVLA

Palvella Therapeutics, Inc. - Common Stock (PVLA)

About Palvella Therapeutics, Inc. - Common Stock (PVLA)

Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.

Details

Daily high

$24.66

Daily low

$23.88

Price at open

$24.58

52 Week High

$29.27

52 Week Low

$11.17

Market cap

268.4M

Dividend yield

0.00%

Volume

43,015

Avg. volume

97,882

P/E ratio

-1.93

Palvella Therapeutics, Inc. - Common Stock News